Elliott, PM;
(2020)
The end of the beginning for drug therapy in obstructive hypertrophic cardiomyopathy with EXPLORER-HCM.
Cardiovascular Research
, 116
(13)
e175-e178.
10.1093/cvr/cvaa282.
Preview |
Text
Elliott_Explorer editorial CVR PE150920.pdf - Accepted Version Download (452kB) | Preview |
| Type: | Article |
|---|---|
| Title: | The end of the beginning for drug therapy in obstructive hypertrophic cardiomyopathy with EXPLORER-HCM |
| Location: | England |
| Open access status: | An open access version is available from UCL Discovery |
| DOI: | 10.1093/cvr/cvaa282 |
| Publisher version: | https://doi.org/10.1093/cvr/cvaa282 |
| Language: | English |
| Additional information: | This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions. |
| Keywords: | Hypertrophic cardiomyopathy, Mavacamten, Cardiac myosin ATPase, Outflow tract obstruction |
| UCL classification: | UCL UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Population Health Sciences > Institute of Cardiovascular Science > Clinical Science |
| URI: | https://discovery.ucl.ac.uk/id/eprint/10116236 |
Downloads since deposit
81Downloads
Download activity - last month
Download activity - last 12 months
Downloads by country - last 12 months
Archive Staff Only
 |
View Item |
